RDSM – Rede de Documentação sobre Saúde em Moçambique

Cost-effectiveness of rotavirus vaccination in Mozambique

Guimarães, Esperança Lourenço; Chissaque, Assecênio; Pecenka, Clint; Clark, Andrew; Vaz, Basília; Banze, Arlindo; Canana, Neide; Romão, Clésio; Martins, Maria do Rosário Oliveira; de Deus, Nilza; Debellut, Frédéric.

Vaccine; 40 (36), 2022

Introduction: Rotavirus is one of the most common cause of severe gastroenteritis in children, with the largest mortality burden in low- and middle-income countries. To prevent rotavirus gastroenteritis, Mozambique introduced ROTARIX vaccine in 2015, however, its cost-effectiveness has never been establi...

Diarreia/tratamento farmacológico, Rotavirus/imunologia, Vacinação/efeitos adversos, Vacinas contra Rotavirus/provisão & distribuição, Análise de Custo-Efetividade/economia, Moçambique/epidemiologia, Diarreia/diagnóstico, Vacinas contra Rotavirus/imunologia, Custos de Cuidados de Saúde/normas, Custos e Análise de Custo/economia, Análise de Custo-Efetividade/organização & administração

Texto completo

Rotavirus disease burden pre-vaccine introduction in young children in Rural Southern Mozambique, an area of high HIV prevalence

PLoS One; 16 (4), 2021

Rotavirus vaccines have been adopted in African countries since 2009, including Mozambique (2015). Disease burden data are needed to evaluate the impact of rotavirus vaccine. We report the burden of rotavirus-associated diarrhea in Mozambique from the Global Enteric Multicenter Study (GEMS) before vaccin...